Investment Analysts’ Updated EPS Estimates for December 2nd (AAPL, APLT, BEG, BNTX, CPB, CYTK, DGHI, EXK, FAN, FAR)

Investment Analysts’ updated eps estimates for Monday, December 2nd: Apple (NASDAQ:AAPL) had its neutral rating reaffirmed by analysts at UBS Group AG. The firm currently has a $236.00 price target on the stock. Applied Therapeutics (NASDAQ:APLT) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a $2.00 target […]

Leave a Reply

Your email address will not be published.

Previous post BeiGene, Ltd. (NASDAQ:BGNE) Short Interest Update
Next post Senseonics (SENS) – Analysts’ Weekly Ratings Changes